快速降低对毒素的敏感性:土耳其的一项描述性研究
Selma Yeşilkaya1, Kurtuluş Aksu1, Gürgün Tuğçe Vural Solak1
1Division of Immunology and Allergy, University of Health Sciences, Ankara Atatürk Sanatory Education and Research Hospital, Ankara, Turkey.
概括
快速药物脱敏 (RDD) 能够有效地控制非小细胞肺癌 (NSCLC) 患者的高敏感性. 这种可靠的程序允许成功完成对过敏个体的必要的纳税治疗.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 药物过敏反应 (DHRs) 在癌症治疗中构成了挑战.
- 塔克桑是非小细胞肺癌 (NSCLC) 的关键化疗药物.
- 管理DHR对于治疗坚持和患者的结果至关重要.
研究的目的:
- 在接受纳税剂的NSCLC患者中描述DHR.
- 评估快速药物脱敏 (RDD) 对于高素过敏的疗效和安全性.
- 评估尽管DHRs,但完成taxane化疗的可行性.
主要方法:
- 在45名高高灵敏的NSCLC患者进行了回顾性横截面研究.
- 标准的3袋,12步RDD协议给所有患者.
- 通过完成循环而没有立即或延迟反应来定义RDD的成功.
主要成果:
- 高成功率:45名患者中有43名 (95.6%) 完成了RDD的纳税循环.
- 总体而言,RDD周期的成功率为98.9% (183个周期中的181个).
- 只有2名患者 (4.4%) 经历了RDD失败.
结论:
- 快速药物脱敏是一种可靠且有效的程序,用于对高素过敏的患者.
- 通过RDD,可以进行并完成一线的分类剂化疗.
- 这种方法改善了患有DHRs的NSCLC患者的治疗选择.
相关概念视频
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


